The reported statements, read against the company's own industry.
Financials view
Market Capitalization
749.82MEUR
822.64M · vs all stocks (USD)
Updated Nov 20, 2026
Trailing P/E
18.83x
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Revenue (TTM)
957.72MEUR
1.05B · vs all stocks (USD)
Updated Nov 20, 2026
Profit Margin
5.36%
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Beta
0.9320x
vs all stocks
Updated Nov 20, 2026
52-Week Change
18.55%
vs all stocks
Updated Nov 20, 2026
Market Capitalization
749.82MEUR
822.64M · vs all stocks (USD)
Updated Nov 20, 2026
Enterprise Value
946.14MEUR
1.04B · vs all stocks (USD)
Updated Nov 20, 2026
Trailing P/E
18.83x
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Forward P/E
16.30x
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Price to Sales (TTM)
0.9121x
vs Medical Instruments & Supplies peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.78×.Updated Nov 20, 2026
Price to Book (MRQ)
1.98x
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Enterprise to Revenue
0.9880x
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Enterprise to EBITDA
10.53x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 9.9×.Updated Nov 20, 2026
Profit Margin
5.36%
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Operating Margin
7.19%
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Return on Assets (TTM)
5.32%
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Return on Equity (TTM)
11.46%
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Revenue (TTM)
957.72MEUR
1.05B · vs all stocks (USD)
Updated Nov 20, 2026
Revenue per Share (TTM)
2.31EURUpdated Nov 20, 2026
Quarterly Revenue Growth
-4.80%
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Gross Profit (TTM)
595.84MEUR
653.71M · vs all stocks (USD)
Updated Nov 20, 2026
EBITDA (TTM)
95.53MEUR
104.80M · vs all stocks (USD)
Updated Nov 20, 2026
Net Income (TTM)
51.37MEUR
56.35M · vs all stocks (USD)
Updated Nov 20, 2026
Quarterly Earnings Growth (YoY)
6.50%
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Operating Cash Flow (TTM)
127.80MEUR
140.21M · vs all stocks (USD)
Updated Nov 20, 2026
Levered Free Cash Flow (TTM)
93.52MEUR
102.60M · vs all stocks (USD)
Updated Nov 20, 2026
Payout Ratio
0.00%
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Minority Interest (Equity)
10.60MEURFY2025 · Dec 31, 2025
Revenue
983.38MEURFY2025 · Dec 31, 2025
Cost of Goods Sold
384.09MEURFY2025 · Dec 31, 2025
Gross Profit
599.29MEURFY2025 · Dec 31, 2025
Operating Income
47.14MEUR
51.72M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
66.96MEURFY2025 · Dec 31, 2025
Income Tax Expense
18.75MEURFY2025 · Dec 31, 2025
Net Income
48.21MEURFY2025 · Dec 31, 2025
EBIT
74.10MEURFY2025 · Dec 31, 2025
EBITDA (Income Statement)
95.53MEURFY2025 · Dec 31, 2025
Selling, General & Administrative
332.06MEURFY2025 · Dec 31, 2025
Other Operating Expenses
17.00MEURFY2025 · Dec 31, 2025
Non-operating Interest Income
2.00MEURFY2025 · Dec 31, 2025
Non-operating Interest Expense
7.14MEURFY2025 · Dec 31, 2025
EPS (Basic)
0.1170EURFY2025 · Dec 31, 2025
EPS (Diluted)
0.1160EURFY2025 · Dec 31, 2025
Basic Shares Outstanding
415.72MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
415.72MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
48.21MEURFY2025 · Dec 31, 2025
Minority Interests (P&L)
433.00KEURFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00EURFY2025 · Dec 31, 2025
Operating Cash Flow
72.14MEURFY2025 · Dec 31, 2025
Free Cash Flow
64.09MEURFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
52.15MEURFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
48.21MEURFY2025 · Dec 31, 2025
Other Non-cash Items
-6.33MEURFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
7.26MEURFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
23.00MEURFY2025 · Dec 31, 2025
Capital Expenditures
-8.05MEURFY2025 · Dec 31, 2025
Net Intangibles (CF)
-2.52MEURFY2025 · Dec 31, 2025
Net Acquisitions
11.88MEURFY2025 · Dec 31, 2025
Other Investing Activity
2.00KEURFY2025 · Dec 31, 2025
Net Investing Cash Flow
3.83MEURFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00EURFY2025 · Dec 31, 2025
Long-term Debt Payments
-30.00MEURFY2025 · Dec 31, 2025
Common Stock Repurchase
-18.00MEURFY2025 · Dec 31, 2025
Common Dividends Paid
-286.00KEURFY2025 · Dec 31, 2025
Net Financing Cash Flow
-47.60MEURFY2025 · Dec 31, 2025
Shares Outstanding
392.11MSharesUpdated Nov 20, 2026
Float Shares
210.13MSharesUpdated Nov 20, 2026
% Held by Insiders
49.49%
vs all stocks
Updated Nov 20, 2026
% Held by Institutions
26.26%
vs all stocks
Updated Nov 20, 2026
Total Cash (MRQ)
73.68MEUR
80.84M · vs all stocks (USD)
Updated Nov 20, 2026
Total Cash per Share (MRQ)
0.1770EURUpdated Nov 20, 2026
Total Debt (MRQ)
79.08MEUR
86.76M · vs all stocks (USD)
Updated Nov 20, 2026
Total Debt to Equity (MRQ)
0.1662x
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Current Ratio (MRQ)
1.78x
vs Medical Instruments & Supplies peers
Updated Nov 20, 2026
Book Value per Share (MRQ)
1.14EURUpdated Nov 20, 2026
Total Assets
758.95MEUR
832.66M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
448.32MEURFY2025 · Dec 31, 2025
Total Liabilities
355.90MEURFY2025 · Dec 31, 2025
Total Non-current Assets
310.63MEURFY2025 · Dec 31, 2025
Total Non-current Liabilities
93.46MEURFY2025 · Dec 31, 2025
Total Current Liabilities
262.44MEURFY2025 · Dec 31, 2025
Cash & Cash Equivalents
52.15MEURFY2025 · Dec 31, 2025
Accounts Receivable
186.61MEURFY2025 · Dec 31, 2025
Inventory
171.25MEURFY2025 · Dec 31, 2025
Accounts Payable
144.52MEURFY2025 · Dec 31, 2025
Short-term Debt
40.61MEURFY2025 · Dec 31, 2025
Other Current Liabilities
3.11MEURFY2025 · Dec 31, 2025
Long-term Debt
57.66MEURFY2025 · Dec 31, 2025
Other Non-current Liabilities
4.38MEURFY2025 · Dec 31, 2025
Common Stock (Book)
384.91MEURFY2025 · Dec 31, 2025
Retained Earnings
-20.85MEURFY2025 · Dec 31, 2025
Total Shareholders' Equity
403.05MEUR
442.19M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
1.50EURUpdated Nov 20, 2026
52-Week High
2.40EURUpdated Nov 20, 2026
52-Week Change
18.55%
vs all stocks
Updated Nov 20, 2026
Beta
0.9320x
vs all stocks
Updated Nov 20, 2026
50-Day MA
1.92EURUpdated Nov 20, 2026
200-Day MA
1.79EURUpdated Nov 20, 2026
Avg 10-Day Volume
1.02MSharesUpdated Nov 20, 2026
Avg 30-Day Volume
631.91KSharesUpdated Nov 20, 2026
Diluted EPS (TTM)
0.1200EURUpdated Nov 20, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.14: safe zoneNotable
Altman Z-Score: 3.14
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Revenue is $1.05B, above the global median of $566.17MNotable